Antibody-drug conjugates (ADCs) are a promising treatment for cancer. They work by getting inside cancer cells and activating the attached drugs to kill the cancer cells. The way ADCs get inside cells and how well they do it is crucial for their effectiveness. Scientists have developed experiments to test how well ADCs get inside cells and ways to improve this process. This research helps identify better antibodies for making more effective ADCs in the future.